Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.03
-0.16 (-5.02%)
At close: Aug 15, 2025, 3:59 PM
3.09
1.98%
After-hours: Aug 15, 2025, 07:48 PM EDT

Protara Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-50.86M -45.41M -44.6M -42.05M -40.69M -42.47M -40.42M -69.17M -67M -64.24M -65.95M -37.21M -40.3M -44.54M -47.25M -45.83M -43.02M -37.38M
Depreciation & Amortization
84K 332K 332K 357K 380K 375K 369K -687K 294K 269K 248K 1.25M 139K 141K 117K 126.98K 199.22K 158.45K
Stock-Based Compensation
3.57M 3.73M 4.13M 4.67M 5.19M 5.74M 6.09M 6.07M 6.06M 6.38M 6.69M 7.17M 8.45M 9.5M 10.36M 10.79M 10.86M 9.69M
Other Working Capital
-1.58M -373K 2.63M 1.49M 1.78M 3.96M 778K 2.27M 537K -449K -92K -556K 1.79M 804K 494K 255.97K -1.19M -129.99K
Other Non-Cash Items
1.68M 1.75M 1.84M 3.78M 3.23M 3.33M 3.42M 32.48M 31.88M 31.88M 32.02M 1.49M 1.75M 1.86M 1.74M 1.91M 2.33M 154K
Deferred Income Tax
n/a n/a n/a -1.74M -2.75M -2.88M -2.88M -1.14M -133K n/a n/a n/a n/a n/a n/a -629K -629K -629K
Change in Working Capital
826K -546K 2.5M -227K 1.31M 855K -4.14M -1.44M -3.77M -2.67M 539K -1.03M 777K -507K 534K -728.93K -700.88K -927.94K
Operating Cash Flow
-44.7M -40.14M -35.81M -35.2M -33.33M -35.05M -37.56M -33.88M -32.67M -28.38M -26.46M -28.34M -29.19M -33.54M -34.5M -34.36M -31.92M -28.18M
Capital Expenditures
-74K -107K -63K -63K -92K -39K -45K -51K -97K -115K -120K -158K -11K -317K -596K -1.06M -1.26M -927K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -9.87K 8.47K 8.47K -5.05K 4.82K 16.41M 16.41M 16.43M 16.43M n/a n/a n/a
Purchase of Investments
-146.89M -95.19M -29.38M -29.38M n/a n/a -12.19M -41.31M -41.31M -43.32M -43.55M -23.22M -39.6M -39.2M -124.75M -115.96M -99.57M -97.96M
Sales Maturities Of Investments
34M 33M 48.6M 40.62M 47.03M 66.39M 65.34M 61.6M 74.32M 67.5M 58.62M 58.56M 55.86M 40.32M 27.15M 16.43M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a 22.35K 32.22K 13.88K 33.01K 24.18K 770.31K -15.64M 769.52K -859K -99.57M -83.15M -99.57M -97.96M
Investing Cash Flow
-112.97M -62.3M 19.16M 11.17M 46.94M 66.35M 53.11M 20.24M 32.91M 24.07M 14.95M 35.18M 16.24M 800K -98.19M -100.59M -100.83M -98.89M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -371.22K -927.41K -927.41K
Common Stock Repurchased
n/a -7K -83K 8K -19K -12K n/a -1K 8K 8K n/a 138K 156K 156K n/a -228K -228K -228K
Dividend Paid
-11K -22K -22K -22K -13K -2K -2K -2K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-174K -111K 74K 78K 69K 6K 6K 2K n/a n/a n/a -228K -228K -228K -228K n/a n/a -371K
Financial Cash Flow
99.59M 141.67M 139.87M 42.02M 41.99M -99K -87K -19K -10K -10K -18K -90K -72K -72K -228K 10.49M 150.31M 149.94M
Net Cash Flow
-58.09M 39.23M 123.21M 17.99M 55.6M 31.2M 15.46M -13.73M 163K -4.4M -11.6M 6.76M -13.02M -32.81M -132.92M -124.47M 17.56M 22.88M
Free Cash Flow
-44.78M -40.25M -35.87M -35.26M -33.42M -35.09M -37.6M -33.93M -32.77M -28.5M -26.58M -28.5M -29.2M -33.86M -35.1M -35.42M -33.18M -29.11M